Costello Asset Management, Inc Uro Gen Pharma Ltd. Transaction History
Costello Asset Management, Inc
- $244 Million
- Q1 2025
A detailed history of Costello Asset Management, Inc transactions in Uro Gen Pharma Ltd. stock. As of the latest transaction made, Costello Asset Management, Inc holds 200 shares of URGN stock, worth $1,156. This represents 0.0% of its overall portfolio holdings.
Number of Shares
200Holding current value
$1,156% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding URGN
# of Institutions
142Shares Held
41.6MCall Options Held
91.4KPut Options Held
42.1K-
Ubs Asset Management Americas Inc Chicago, IL4.36MShares$25.2 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY3.83MShares$22.2 Million0.69% of portfolio
-
Ra Capital Management, L.P. Boston, MA3.21MShares$18.5 Million0.74% of portfolio
-
Menora Mivtachim Holdings Ltd.2.3MShares$13.3 Million0.17% of portfolio
-
Black Rock Inc. New York, NY2.19MShares$12.7 Million0.0% of portfolio
About UroGen Pharma Ltd.
- Ticker URGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 22,740,500
- Market Cap $131M
- Description
- UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...